Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
The latest announcement is out from Guangdong Kanghua Healthcare Co., Ltd. Class H ( (HK:3689) ).
Guangdong Kanghua Healthcare Group Co., Ltd. has announced a delay in the dispatch of a shareholder circular related to its 2026 lease agreements, which constitute major and connected transactions under Hong Kong listing rules. The circular, originally scheduled for release on or before 15 January 2026, will now be sent by 30 January 2026 to allow additional time to finalize certain information, slightly extending the timetable for shareholders’ review and independent assessment of the proposed lease arrangements.
The most recent analyst rating on (HK:3689) stock is a Hold with a HK$2.00 price target. To see the full list of analyst forecasts on Guangdong Kanghua Healthcare Co., Ltd. Class H stock, see the HK:3689 Stock Forecast page.
More about Guangdong Kanghua Healthcare Co., Ltd. Class H
Guangdong Kanghua Healthcare Group Co., Ltd. is a healthcare services provider based in the People’s Republic of China and listed in Hong Kong, operating under a board structure that includes executive, non-executive and independent non-executive directors, reflecting standard corporate governance practices for a listed medical group.
Average Trading Volume: 12,440
Technical Sentiment Signal: Strong Sell
Current Market Cap: HK$601.9M
See more insights into 3689 stock on TipRanks’ Stock Analysis page.